J. Eisfeld et al., INHIBITION OF CLONED HUMAN L-TYPE CARDIAC CALCIUM CHANNELS BY 2,3-BUTANEDIONE MONOXIME DOES NOT REQUIRE PKA-DEPENDENT PHOSPHORYLATION SITES, Biochemical and biophysical research communications, 230(3), 1997, pp. 489-492
The oxime derivative 2,3-butanedione monoxime (BDM) is used as an inor
ganic phosphatase to probe the phosphorylation state of many cellular
proteins including the L-type calcium channel in various tissues. We u
sed BDM further to shed light on the controversy surrounding direct ph
osphorylation of the L-type Ca2+ channel. We employed a recombinant sy
stem that utilizes HEK 293 cells expressing wild type and mutant human
heart calcium channels. BDM reversibly reduced the calcium channel cu
rrent induced by expression of the wild type channel in a concentratio
n-dependent manner with an apparent IC50 value of 15.3 mM. Deletion of
part of the carboxyl terminus of the alpha(1) subunit, which contains
one putative protein kinase A site, or mutating all of the protein ki
nase A consensus sites of the pore forming subunit, did not significan
tly change the apparent IC50 value or alter in any other way the block
ing effect of BDM on the expressed currents. Our data suggest that BDM
produces reversible modifications of the cardiac calcium channel prot
ein leading to an expected reduction in the amplitude of the expressed
currents, but the site of action must be different from that of the c
onsensus sites for protein kinase A dependent phosphorylation. (C) 199
7 Academic Press.